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MiR-125a enhances self-renewal, 
lifespan, and migration of murine 
hematopoietic stem and progenitor 
cell clones
Edyta Ewa Wojtowicz, Mathilde Johanna Christina Broekhuis, Ellen Weersing, 
Alexander Dinitzen, Evgenia Verovskaya, Albertina Ausema, Martha Ritsema,  
Erik Zwart  , Gerald de Haan & Leonid V. Bystrykh
Expansion of hematopoietic stem cells (HSCs) is a ‘holy grail’ of regenerative medicine, as successful 
stem cell transplantations depend on the number and quality of infused HSCs. Although many attempts 
have been pursued to either chemically or genetically increase HSC numbers, neither clonal analysis 
of these expanded cells nor their ability to support mature blood lineages has been demonstrated. 
Here we show that miR-125a, at the single cell level, can expand murine long-term repopulating HSCs. 
In addition, miR-125a increases clone longevity, clone size and clonal contribution to hematopoiesis. 
Unexpectedly, we found that miR-125a expanded HSCs clones were highly homogenously distributed 
across multiple anatomical sites. Interestingly, these miR-125a overexpressing cells had enhanced 
mobility and were more frequently detected in the spleen. Our study reveals a novel, cell-intrinsically 
controlled mechanism by which HSC migration is regulated.
Hematopoietic stem cell (HSC) transplantation constitutes an important treatment modality for multiple hema-
tological disorders, including leukemia. Successful stem cell transplantation largely depends on the number 
of HSCs that is infused and engrafts. Strategies to improve the efficiency of bone marrow (BM) reconstitution 
after HSC transplantation have focused on attempts to increase homing of HSCs to the BM or alternatively to 
expand HSCs ex vivo using chemical1 or genetic approaches2. Although there has been progress in developing 
HSC expansion protocols3, their value for the clinics is still under debate. Whereas under normal conditions 
HSCs are retained and engraft locally in the BM it is postulated that there may be a maximal capacity of the bone 
cavity to host HSCs, and expansion beyond such limit may result in HSCs egressing to the circulation resulting in 
extramedullary hematopoiesis. Interestingly, various inbred strains of mice have different sizes of the HSC pool4,5, 
and increased stem cell pool size in these strains correlate with the efficacy to induce HSC mobilization from bone 
marrow to blood4.
To identify molecular contributors to these genetically regulated qualitative and quantitative HSC-intrinsic 
differences, we performed genome-wide mRNA6 and microRNA7 expression studies. The latter analysis revealed 
an increased expression of the microRNA-99b-let7e-125a cluster in the DBA/2 strain, a strain that displays 
increased HSC numbers and enhanced mobilization compared to C57BL/67. It appeared that miR-125a largely 
accounted for the proliferative advantage and increased self-renewal in cells overexpressing this miRNA cluster7,8.
To develop alternative strategies to improve hematopoietic reconstitution after transplant, we recently showed 
that it is feasible to induce functional stem cell activity in progenitors, which are normally devoid of long-term 
repopulating potential by enforcing expression of miR-125a in committed progenitors. In the current paper we 
asked whether, at the single cell level, miR-125a overexpression could truly expand murine long-term repopulat-
ing HSCs and how this would affect the peripheral blood cell contribution of these cells over time. In addition, 
we explored whether enforced HSC expansion is associated with ‘saturation’ of the stem cell supporting potential 
of the BM, and whether saturation leads to stem cell migration. To this end we used a state-of-the-art cellular 
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barcoding method to trace the clonal behavior and blood contribution of expanded HSCs and progenitors and 
analyze their skeletal allocation. We document for the first time the feasibility of clonal expansion of HSC and 
progenitors. Mir-125a strongly increased HSC clone number, clone size, clone longevity, and migration, leading 
to symmetrical distribution of clones throughout the skeleton. Furthermore, these cells showed increased respon-
siveness to G-CSF in vitro and in vivo and downregulation of c-Kit expression. We employed a mathematical 
model, which suggested that an increased self-renewal and slower differentiation rate of HSCs overexpressing 
miR-125a contribute to their expansion.
Results
MiR-125a overexpression increases the number and the size of HSPC clones. Counting HSCs 
and their progeny, as well as clonal analysis of the hematopoietic lineages has been a technical challenge for a 
long time. Recently, implementation of cellular HSC barcoding has allowed unprecedented insight into clonal 
behavior of HSCs. Principles and concepts of this method have been described in several recent reviews9,10. Here 
we used a cellular barcoding method to accurately quantify numbers and contribution of stem cells and pro-
genitors to blood lineages to follow the dynamics and longevity of hundreds of individual clones. We isolated 
LT-HSC (defined as Lin−Sca-1+cKit+CD150+CD48− cells11) and progenitors (defined as Lin−Sca-1+cKit+ cells, 
depleted from CD150+CD48− cells12, (for gating strategy see Supplementary Fig. 1) and transduced these with 
control or a miR-125a overexpressing barcoded libraries prior to transplantation in two cell doses into lethally 
irradiated recipients (Fig. 1A). MiR-125a overexpression levels are shown in Fig. 1B, and transplanted cell doses 
are provided in Supplementary Table 1. We collected blood samples every 4-weeks and FACS-purified granu-
locytes (SSChiGr-1+), B cells (B220+), T cells (CD3ε+) and nucleated erythroid cells (Ter-119+)13 in cohorts of 
mice transplanted with LT-HSC (n = 5) or progenitors (n = 3) transduced with barcoded control vector (CV), or 
with LT-HSC (n = 8) or progenitors (n = 7) transduced with barcoded miR-125a vector. We extracted genomic 
DNA, amplified barcode sequences and subjected samples for sequencing as previously described14. Clones were 
counted in two different ways. We refer to clones as “consistent” if they were reproducibly detected in series of 
at least 2 consecutive samples. In this case no restrictions were made on their actual contribution to blood pro-
duction. Using this parameter we counted up to 50 clones in mice transplanted with LT-HSCs or progenitors 
transduced with CV at week 4 post-transplant, whereas up to 200 clones were detected in mice transplanted 
with miR-125a OE cells (Fig. 1C). Although after 24 weeks we observed a decrease in the number of clones in all 
analyzed groups (Fig. 1C, Supplementary Fig. 2A–D), still miR-125a overexpressing cells retained an increased 
number of stably detected clones compared to control cells. Alternatively, when we focused on clones that con-
tributed to the myeloid lineage more than 0.5% (we refer to these as ‘contributing clones’) the number of clones 
was smaller for all time points, since the contribution of a considerable number of detected clones was below this 
threshold (Fig. 1D, Supplementary Fig. 3A–D). We did observe a correlation between the number of transplanted 
HSC and the number of contributing clones (Fig. 1D), and did detect a significant difference between CV and 
miR-125a OE cells at 24 weeks post transplantation.
As expected, control progenitors reconstituted lethally irradiated recipients poorly (0–2% and only 0–4 bar-
codes detected in all analyzed animals), did not contribute to long-term hematopoiesis (Fig. 1E, second panel), 
and therefore this group was excluded from further analysis. The contribution of control LT-HSC clones to mye-
loid reconstitution varied from 0.5% up to maximally 6% (Fig. 1E first panel, Supplementary Excel File provides 
blood contribution of each clone). Our results show that the increased engraftment of miR-125a OE cells coin-
cides with a higher number of clones that significantly contribute more to hematopoiesis, from 0.5% up to 16% to 
short-lived granulocytes (Fig. 1E, third and fourth panel). These data show an increased number of HSC and pro-
genitor clones that efficiently engraft and differentiate upon miR-125a OE and sustain robust reconstitution upon 
transplantation (chimerism levels reaching almost 100% already 4 weeks post-transplant, Fig. 1E). Interestingly, 
miR-125 OE LT-HSCs and progenitors formed significantly larger clones compared to CV LT-HSC (Fig. 1F).
As miR-125a OE expands HSCs at the clonal level, we asked to what extent each clone contributed to the 
production of granulocytes, B-cells, T-cells, and erythroid cells (examples of multilineage clonal composition 
are shown in Fig. 2A–C). Therefore, we compared the lineage contribution of ~200 control LT-HSCs, ~650 
miR-125a-expressing LT-HSCs and ~700 miR-125a expressing progenitors (Fig. 2D–F). As has been reported 
before, granulocytes and lymphocytes are often produced by different subsets of primitive cells14,15. Interestingly, 
here we detected a separate group of clones that preferentially supported the erythroid lineage in normal LT-HSC 
(Fig. 2D). This primitive cell subset has remained unnoticed in previous studies, most likely because analysis 
of the erythroid lineage was omitted or performed only once at terminal analysis precluding the kinetic stud-
ies14–16. We did not detect this group of clones in cells overexpressing miR-125a (Fig. 2E–F). Moreover, in mice 
transplanted with miR-125a OE progenitors we identified a subgroup of lymphoid biased primitive cells (mainly 
supporting B-cells and to a smaller extent T cells) that constituted ~1/3 of all detected clones (Fig. 2F). This sub-
group was functionally different from the group exclusively supporting B cell production and was absent in all 
other analyzed groups (Fig. 2F). Unexpectedly, we did not observe any clones preferentially contributing to the 
myeloid lineage in mice transplanted with miR-125 OE progenitors, which were expected based on miR-125a 
induced myeloid skewing and myeloproliferation7,8,17–19. However, in miR-125a OE LT-HSC we did detect ~10% 
of myeloid biased clones and an increased fraction (over 1/3 of all analyzed clones) of balanced HSCs, supporting 
all mature blood lineages (Fig. 2E).
In the majority of analyzed mice we observed that different clones supported different mature blood lineages 
(Supplementary Fig. 4A). However, there was one exception: in mice transplanted with miR-125a OE LT-HSC 
and progenitor cells we observed a higher overlap between barcodes detected in erythroid and myeloid lineages as 
compared to control LT-HSC (Supplementary Fig. 4A–C). Therefore, expanded LT-HSCs and progenitors reveal 
a mild alteration in the lineage commitment.
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MiR-125a overexpression extends clonal life span upon serial transplantation. To assess whether 
miR-125a-induced expansion affects HSC clonal self-renewal or clonal lifespan, we collected cells isolated from 
various skeletal locations (spine, right or left femur, front legs and sternum or skull) from individual primary 
recipients and transplanted 5 million cells into lethally irradiated secondary and tertiary recipients (Fig. 3A,B, 
Supplementary Fig. 5A,B). We repeatedly bled mice and analyzed the clonal composition in Gr-1+ SSChi cells 10 or 
12 weeks after 2nd and 3rd transplantation. In these figures (Fig. 3A,B) each detected barcode is depicted as a circle, 
where the size of the circle indicates clone size (the scaling of clone size is shown in the figure, the colors of the 
circle indicate the skeletal origin of BM cells transplanted into recipient mouse). We analyzed the clones present 
Figure 1. Ectopic miR-125a expression expands LT-HSC pool, endows the self-renewal potential to progenitors 
and increases clone size. (A) Experimental set up. Lin−Sca+Kit+CD150+48− (LT-HSCs) were separated from 
the remaining Lin−Sca+Kit+ cells (progenitors) by FACS, and transduced with barcoded control vector or miR-
125a libraries. Transduced cells were transplanted into lethally irradiated C57BL/6 mice. Recipient mice were 
bled every 4 weeks to FACS-sort Gr-1+, Ter-119+, B220+ and CD3+ cells for barcode analysis. (B) qPCR data 
showing the relative overexpression level of miR-125a to empty vector. Sno202 was used for the normalization. 
(C) Number of clones that contributed >0.5% to myeloid lineage 4 and 24 weeks post transplantation 
(unpaired student t-test, *p < 0.01). (D) Number of consistently contributing clones detected 4 or 24 weeks 
post transplantation in myeloid lineage (unpaired student t-test, *p < 0.01). Each symbol represents a single 
mouse, (E) Myeloid clone sizes (contributing >0.5% to granulocytes) in blood at 12 weeks post transplantation 
in control progenitors, miR-125a overexpressing progenitors, control LT-HSC and miR-125a overexpressing 
LT-HSC Above each column the number of contributing clones (>0.5%) is depicted. (F) Summary of clone 
sizes depicted in panel E (in peripheral blood), miR-125a OE progenitors form larger clones as compared to CV 
LT-HSC (p < 0.0001, unpaired t-test, two-tailed) and miR-125a OE LT-HSC (p = 0.015, unpaired student t-test). 
MiR-125a OE LT-HSC form significantly larger clones as compared to CV LT-HSC (p < 0.0001, unpaired t-test, 
two-tailed).
www.nature.com/scientificreports/
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in peripheral blood (depicted as detected in 1° PB) and bone marrow (depicted as not detected in 1° PB) in the 
primary recipient. Not all clones detected in the BM were present in PB. Next, we compared the clones detected 
in PB of secondary and tertiary recipients with those found in PB and BM of the primary recipients. We have 
observed that some of clones found only in the BM of the primary recipient contributed to PB hematopoiesis in 
serially transplanted recipients (detected clones in primary recipients are shown within black rectangles - the 1st, 
6th or 11th column of circles in Fig. 3A or the 1st column in Fig. 3B). We ranked the detected barcodes in the PB of 
each primary recipient from the highest to lowest contributing clones (counting only clones contributing >0.5% to 
Figure 2. MiR-125a mildly influences lineage choice decision. (A) Barcode composition in granulocytes, 
erythroid cells, B cells and T cells in a mouse transplanted with CV LT-HSC (B) A mouse transplanted with 
miR-125a overexpressing LT-HSC (C) A mouse transplanted with progenitors overexpressing miR-125a (D) 
Relative lineage contribution of indicated number of clones detected at 12 and 16 weeks post transplantation 
in mice transplanted with control LT-HSC, (E) miR-125a overexpressing LT-HSC or (F) progenitors (n = 3 for 
each condition).
www.nature.com/scientificreports/
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granulocytes Fig. 3A,B, Supplementary Fig. 5A,B). Same barcodes detected in blood of primary and serially trans-
planted recipients are plotted in the same row. In 7 out of 9 secondary recipients transplanted with CV LT-HSC we 
detected clones that were not active in the primary recipient, but significantly contributed to hematopoiesis upon 
serial transplantation (Fig. 3A, Supplementary Fig. 5A,B). In secondary recipients transplanted with CV LT-HSC 
we observed that the number of clones contributing to the myeloid lineage was low (on average 4 clones) with low 
contribution to hematopoiesis, therefore precluding a 3rd round of transplantation. We detected a similar pattern 
of ‘reactivated’ clones in mice serially transplanted with miR-125a OE LT-HSC (Fig. 3B, Supplementary Figs 5C,D 
and 6A,B for two additional serial transplantation experiments). However, miR-125a expanded cells survived and 
repopulated lethally irradiated recipients more robustly compared to CV LT-HSC, since secondary and tertiary 
recipients were highly chimeric (80–90% chimerism in SSChiGr-1+ cells) and showed an increased number of 
contributing clones, compared to control (Fig. 3B, Supplementary Figs 5A,B, 6A,B).
To summarize, CV LT-HSC clones that were dominant in primary recipients displayed only restricted con-
tribution to hematopoiesis in serial transplantations. In contrast, miR-125a expanded cells showed significantly 
Figure 3. MiR-125a extends clonal lifespan, while serial transplantation ‘activates’ dormant clones (A) Serial 
transplantations of control LT-HSC or (B) miR-125a overexpressing LT-HSC. Barcoded bone marrow cells 
were isolated from multiple skeletal regions of primary recipients, and serially transplanted (origin of cells 
depicted over mouse pictogram). Clonal make-up in secondary (and tertiary) mice was compared with clonal 
make-up of the primary recipient that served as bone marrow donor. The color code indicates which clones 
were originating from which mouse. Size of the clone is indicated by the size of the circle (to estimate the 
relative contribution to granulocytes, the barcode representation in granulocytes was divided by total barcode 
representation (granulocytes+ Ter-119+ T cells+ B cells). Many clones that were detected in the peripheral 
blood of secondary recipients were also present in the blood of the primary recipient (detected in 1° PB). 
However, some secondary clones were only present in the bone marrow of the primary recipient (indicated 
by ‘not detected in 1° PB′). Only clones that contributed at least 0.5% to Gr-1+ at week 16 are shown for the 
primary recipient).
www.nature.com/scientificreports/
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Figure 4. MiR-125a overexpression redistributes clones across the skeleton. (A) Schematic representation of 
the 5 bone groups that were analyzed. (B) Bone marrow cellularity (expressed as a total number of nucleated 
cells) and (C) Total number of LT-HSC (Lin-Sca+ Kit+ CD150+ 48-) isolated from various skeletal locations 
(D). Skeletal distribution of barcoded clones in control LT-HSC, (E) miR-125a overexpressing LT-HSC, or 
(F) Progenitors. (G) Comparison of the clone sizes formed in the bone marrow (of mice depicted in D–F). 
Progenitors OE miR-125a form fewer, larger clones as compared to CV LT-HSC (p < 0.0001, unpaired Student 
t-test, two-tailed) or miR-125a OE LT-HSC (p = 0.048, unpaired Student t-test, two-tailed). For the 20 most 
abundant clones we calculated their relative abundance in the skeletal site where they were found 12 weeks post 
transplantation in mice transplanted with control LT-HSC (H), with miR-125a overexpressing LT-HSC (I), and 
with miR-125a overexpressing progenitors (J). Similar patterns were observed in other analyzed mice (data 
not shown). (K) Relative standard deviations for the distribution of clones found in mice transplanted with CV 
LT-HSC (n = 2), miR-125a LT-HSC (n = 3), miR-125a progenitors (n = 2) at 12 weeks post transplantation. 
www.nature.com/scientificreports/
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extended clonal longevity and function, resulting in more clones with higher contribution to hematopoiesis in 
serial transplantations.
Multiple viral integrations and dose effect. We asked whether an increased dose of miR-125a expres-
sion, induced by multiple miR-125a copies in the same cell, would be associated with enhanced stem cell activity 
and whether these cells would be positively selected for in the course of serial transplantations. The odds of a 
cell being infected with multiple viruses increases proportionally to the transduction efficiency (Supplementary 
Fig. 7A). When barcoded vectors are used, such events can be recognized by an unusually high degree of correla-
tion between multiple barcodes.
To monitor clones and describe their competitive behavior over time we analyzed their blood cell contribution 
by ranking barcodes in primary and secondary recipients according to clone size in PB and BM. Strikingly, in CV 
LT-HSC and CV progenitors we detected fewer clones with multiple vector copy number per cell than expected 
by chance (Supplementary Fig. 7A,D,E). This suggests that multiple integrations of the vector in the genome may 
be detrimental to cells. This observation is in contrast to the common believe that multiple hits in the genome are 
prone to positive selection20,21. In contrast, miR-125a expanded stem and progenitor cells followed frequencies 
of single and multiple vector copy number integrations as expected by chance, implying no selective pressure 
on the vector copy number counted per cell in primary recipients (Supplementary Fig. 7B,C). However, we did 
observe positive selection for multiple hit clones overexpressing miR-125a in the 2nd round of transplantation 
(Supplementary Fig. 7F,G). This suggests that better engraftment, extended lifespan and increased self-renewal is 
indeed miR-125a dose-dependent.
MiR-125a induced expansion of HSCs results in homogenous distribution of clones throughout 
the skeleton. Since miR-125a significantly expands the number of clones that support hematopoiesis, we 
wished to address whether the expanded HSC pool would exceed the capacity of the BM to host them. To this end 
cells were obtained from front limbs and sternum, the left hind limb, the right hind limb, the skull, and from the 
spine (Fig. 4A). Both the total yield of nucleated cells (Fig. 4B) and LT-HSCs (Fig. 4C) was distinct for each site. 
Particularly spine turned out to be a wealthy, and generally overlooked, source of LT-HSCs. Mice transplanted 
with CV LT-HSC, miR-125a OE LT-HSC or progenitors were sacrificed at 12 or 24 weeks post transplantation. 
We isolated cells from various locations and sorted Lin−c-kit+ cells from those to assess barcode distributions.
As we and others have showed before, the distribution of barcoded clones derived from control HSCs in these 
anatomical sites was highly asymmetrical (Fig. 4D, Supplementary Fig. 8A for more examples)22,23. Clones that 
were dominant and constituted ~20% of all clones at one site, were often barely detectable at other sites. This sug-
gests that upon transplantation, HSC seed a local BM niche and not readily egress to the circulation22.
In contrast, the clonal makeup in mice transplanted with barcoded miR-125a expanded LT-HSCs or progen-
itors was highly symmetrical (Fig. 4E,F and Supplementary Fig. 8B,C). As shown before in the peripheral blood 
(Fig. 1F), we observed that miR-125a overexpression increased BM clone size (Fig. 4G). In total we evaluated 7 
control and 10 miR-125a transplanted mice, and consistently, in each mouse transplanted with a high number of 
miR-125a OE cells, primitive cells were symmetrically distributed across all tested locations of the skeleton (exp. 
2, Suppl. Table 1) and in the spleen. For any individual control clone, the contribution to the local BM compart-
ment varied widely from 1 to 37% (Fig. 4H, Supplementary Fig. 8D). In contrast, clones formed by LT-HSC or 
progenitors expanded by miR-125a showed a very narrow size range across all skeletal locations, despite their 
different size and capacity to host HSC (Fig. 4I,J, Supplementary Fig. 8E,F). These data suggest that miR-125a 
expanded HSCs saturate the available ‘space’ and colonize other sites including the spleen. In agreement, the 
barcode clonal make up in the spleen was similar to that found in other analyzed skeletal locations (Fig. 4E,F).
To quantitatively assess the clonal asymmetry we calculated the relative standard deviation (RSD) for the aver-
age clone size in different bones (for details see22). The mean RSD for CV LT-HSC clones was 0.84, whereas for 
miR-125a expanded LT-HSC and progenitors the RSD was 0.22 and 0.24, respectively (Fig. 4K). To test whether 
the asymmetrical skeletal distributions in control mice would equalize in time, we analyzed an additional 3 mice/
condition at 24 weeks post transplantation. Again, however, we found a diverse skeletal distribution for CV 
LT-HSC and a symmetrical distribution for miR-125a OE cells (Supplementary Fig. 8G).
We hypothesized that the miR-125a expanded HSC pool resulted in saturation of BM niches. To test this we 
transplanted lower numbers of expanded HSC, which would be expected to result in asymmetrical clonal dis-
tribution. (Suppl. Table 1, exp.1-cell doses). Indeed, the skeletal distribution of miR-125a expanded HSC clones 
24 weeks post transplantation now was highly asymmetrical and had a similar skeletal distribution compared to 
non-expanded control cells (Fig. 4L,M). These data support our hypothesis that indeed excessive HSC expansion 
saturates BM niches.
To explore the contribution of stem cell dose and stem cell clone size to BM niche saturation (measured by 
the extent of clonal symmetry) we developed a mathematical model of clonal engraftment and clonal distribution 
(Supplementary Power Point presentation). We defined the number of HSCs (cells) and skeletal locations avail-
able for hosting HSCs (bins). The model allows HSCs to locally expand and if their number exceeds the hosting 
capacity of the BM compartment, cells are forced to enter the blood and migrate to other locations, or differen-
tiate (the model controls the rate of differentiation). The model repeats this process n-times and plots the result-
ing skeletal distribution of HSC clones by depicting the relative standard deviation of clonal distribution across 
Horizontal lines indicate the mean value. The difference between the groups was assessed by two-tailed Mann-
Whitney test (***P < 0.0001). (L,M) The skeletal distribution of miR-125a OE clones when transplanted at 
lower dose (cell dose in Suppl. Table 1), depicted are two individual mice.
www.nature.com/scientificreports/
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the various bone marrow sites. As expected, a higher dose of transplanted cells shortened the phase of initial 
local, clonal expansion (latent phase) and stimulated rapid clonal equilibration between distinct skeletal locations 
(Fig. 5A,B). If HSCs that leave the niche would mostly differentiate, clonal disequilibrium could be maintained 
practically endlessly (Fig. 5C). However, if only a small fraction of migrating cells (in our simulation 1/30th of 
them) would differentiate, after 30 generations we would observe full skeletal equilibration (Fig. 5D, Suppl. Power 
Point presentation). As in our experimental studies we observed a faster equilibration across the skeleton upon 
miR-125a expression (Fig. 4E,F) our model predicts that this results likely from enhanced self-renewal divisions 
and/or lower differentiation rate.
MirR-125a expanded HSC and progenitors are migrating in the peripheral blood at steady state 
and are mobilized in response to G-CSF. During steady state hematopoiesis, no or very few hemato-
poietic progenitors can be cultured from the PB. To assess whether miR-125a induced HSC expansion causes 
BM saturation and results in spontaneous progenitor cell mobilization, we evaluated the number of clonogenic 
progenitor cells in PB from control and miR-125a transplanted mice. Indeed, the frequency of cells with clono-
genic potential was ~10-fold higher in the PB of mice transplanted with miR-125a OE cells compared to controls 
(Fig. 6A). In addition, we quantified the number of progenitors with clonogenic potential in the spleen to measure 
extramedullary hematopoiesis, and detected a strong increase in mice transplanted with miR-125a expanded cells 
(Fig. 6A). There was a moderate difference in the number of colony forming progenitors in the BM of miR-125a 
or control mice (Fig. 6A), indicating that the progenitor pool in the BM remained largely unaffected by miR-125a 
Figure 5. Mathematical modelling of HSC clone equilibration as a function of the size of bone marrow niche, 
self-renewal and differentiation potential Panels A, B, and C show dynamics of the equilibration of two clones 
(orange and blue lines) across 10 bones. (A) Three major phases of clone dynamics are indicated. Shortly after 
transplantation clones are seeded at random in 10 bones; a latent phase with a high degree of asymmetry. 
Once niches become saturated (arbitrary at 50 cells per bone), clonal equilibration begins and cells leave the 
bone and enter the circulation, resulting a stationary phase with low asymmetry. Note, that by changing the 
differentiation factor (A) versus (B), equilibration is affected. If the self-renewal rate is altered (A) versus (C), 
the latent phase becomes shorter and equilibration is more rapidly achieved. We refer to a state of equilibrium 
when clones become equal in size and no further decline of StDev/Average occurs. More details are given in 
the supplementary Powerpoint presentation. (D) Snapshot of the clonal dynamics at equilibrium; the complete 
dynamic gif file can be found in the supplementary presentation.
www.nature.com/scientificreports/
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OE. To further evaluate whether cells with long-term repopulating ability were also present in the peripheral 
blood, we isolated Lin-GFP+ cells from primary transplanted recipients and injected these into lethally irradi-
ated secondary recipients. Within tested cell dosage (Supplementary Table 2) we did not observe engraftment. 
However, mice transplanted with cells isolated from the spleen of miR125a-OE mice fully reconstituted recipi-
ents. (Supplementary Table 2). This suggests that miR-125a leads to the migration of stem and progenitor cells 
from the bone marrow, and accumulation of LT-HSCs in the spleen.
Figure 6. MiR-125a OE induces the presence of CFU-GM in the peripheral blood and enhances their 
responsiveness to G-CSF (A) CFU-GM colonies grown from cells isolated from bone marrow, spleen and 
peripheral blood. Shown are 3 mice/condition, different colors represent different mice, circles represent mice 
transplanted with control cells while squares reflect mice transplanted with miR-125 OE cells. The two last data 
points show the number of white blood cells measured in the peripheral blood at the moment of cell isolation 
(note right Y-axis), Statistical significant differences were observed between CV and miR-125a OE (BM 
p = 0.0271, SPL p < 0.0001, PB p < 0.0001 Mann-Whitney non-parametric test). (B) The response of Lin-c-Kit+ 
GFP+ progenitors to increasing concentration of G-CSF in vitro, measured as the number of formed CFU-GM 
colonies. Circles represent control, squares miR-125a overexpressing cells. (C) Michaelis-Menten curve for 
control or miR-125a overexpressing cells, generated using the on-line script: http://ic50.tk/kmvmax.html, 
(D) Hanes – Woolf transformation of Michaelis-Menten equation for control and miR-125a OE cells. (E) The 
number of CFU-GM in increasing volumes of peripheral blood isolated from mice transplanted with control 
or miR-125a OE cells after G-CSF administration. (F) qPCR analysis of STAT3 and Socs3 expression in FACS 
purified Lin-cKit + eGFP + cells from mice transplanted with CV or miR-125a OE cells. (G) c-Kit expression 
levels in Lin-Sca-Kit + cells isolated from animals transplanted with CV or miR-125a OE cells.
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The equal skeletal distribution of miR-125a expanded clones was very similar to patterns we observed previ-
ously upon G-CSF administration and is very different from steady-state where clones are asymmetrically dis-
tributed in the skeleton22,23. As both exogenous G-CSF administration and endogenous miR-125a OE result in 
skeletal equilibration of clones, we asked whether miR-125a OE would render cells more responsive to exoge-
nously administered G-CSF. To this end hematopoietic progenitors (L−K+eGFP+) were isolated from BM of mice 
transplanted with control or miR-125a OE LT-HSCs, and subsequently cultured in increasing concentrations 
of G-CSF (Fig. 6B). Indeed, miR-125a OE led to a strong G-CSF induced increase of their clonogenic poten-
tial. In low G-CSF concentration we observed CFU-GM colonies derived from L−K+eGFP+ expressing miR-
125a, but not in control cells. Analysis of the dose sensitivity (KM) and the maximal response (VMAX) of control 
and miR-125a OE LT-HSC to G-CSF revealed similar sensitivity of both cell types (mice transplanted with CV 
LT-HSC KM = 1.59 ± 0.69, or miR-125a OE LT-HSC KM = 0.43 ± 0.21). However, the maximal response was 
higher for miR-125a OE LT-HSC and significantly different from CV LT-HSC (CV VMAX = 5.31 ± 0.77, miR-125a 
VMAX = 9.48 ± 1.27, Fig. 6C,D).
Encouraged by the in vitro data we next evaluated the responsiveness of miR-125a expressing cells to G-CSF 
in vivo, by injecting mice transplanted with control or miR-125a expanded cells with a suboptimal dose of this 
growth factor. We initiated CFU-GM assays using PB cells isolated 3 days after administration of a single dose 
of G-CSF, and observed a significantly increased number of colonies formed by cells OE miR-125a compared to 
control cells (Fig. 6E). Informed by our own and reports from others12,24 we screened for miR-125a targets that 
have been reported to be involved in G-CSF signal transduction and/or cell mobility. We evaluated the expression 
levels of Socs3, a negative regulator of G-CSF signaling, and a direct target of Stat3 (which is a known target of miR-
125a24) but we did not observe any difference at the expression level between CV and miR-125a (Fig. 6F). C-Kit, 
another predicted miR-125a target, has been reported as a key receptor regulating the interaction niche-HSC25,26 We 
observed decreased protein expression upon miR-125a OE (Fig. 6G). Therefore, we postulate that enhanced migra-
tion of HSCs upon miR-125 OE is due to downregulation of c-Kit expression, rather than sensitization to G-CSF.
Discussion
In the current paper we assessed whether, at the single cell level, miR-125a overexpression can truly expand 
murine long-term repopulating HSCs. We used a state-of-the-art cellular barcoding approach to detect that 
indeed, miR-125a overexpression causes an increased number of HSC clones that contribute to multilineage 
engraftment after transplant. In addition, miR-125a substantially increases clone longevity, clone size and clonal 
contribution to hematopoiesis in long-term serial transplantation experiments. Unexpectedly, we identified cells 
with a clonogenic potential in the peripheral blood in miR-125a transplanted mice during steady state hemato-
poiesis. This strongly indicated that miR-125a causes enhanced HSC trafficking from the BM to the circula-
tion. Indeed, when we explored how uniquely barcoded HSCs were distributed across many skeletal sites, we 
found that, in contrast to wild type HSCs, miR-125a expanded HSCs were highly homogenously distributed. 
Interestingly, these cells were more sensitive to G-CSF, in vitro and in vivo, possibly contributing to observed 
increased cell mobility through downregulation of c-Kit expression. To the best of our knowledge, our data are 
the first to document the feasibility of clonal HSCs expansion, and of increasing clonal HSC lifespan. Our study 
reveals also a novel, cell-intrinsically controlled mechanism by which HSC mobilization is regulated.
There are several potential mechanisms that may explain why miR-125a overexpression causes HSC to 
migrate. First, as miR-125a overexpression results in a significant expansion of the total stem cell pool size, it is 
possible that the number of niches that is available to support stem cells becomes limiting, and excessive stem cells 
are forced to migrate to secondary hematopoietic organs. Niche saturation may become even more prominent as 
we have shown recently that miR-125a overexpression in progenitors induces stem cell potential in these commit-
ted cells12. Although our molecular and physiological understanding of the HSC niche remains very incomplete, 
it is interesting to note that in clinical conditions in which the restricted BM niche fails to support stem cells, most 
notably in osteopetrosis, HSCs leave marrow and seed extramedullary sites27.
A second, not mutually exclusive, mechanism why miR-125a overexpression may cause spontaneous HSC 
mobilization is that it increases the responsiveness of cells to mobilization-inducing cytokines, most notable 
G-CSF. It is well-known that after G-CSF administration, a selected subset of primitive cells is preferentially 
mobilized from the BM to peripheral blood28,29. It is also interesting to note that genetically regulated differences 
in miR-125a expression correlate with stem cell pool size and G-CSF induced cell mobilization in DBA/2 and 
C57BL/6 mouse strains7. It is unknown how miR-125a expression is controlled in HSCs, but as the miR-125a 
locus is highly conserved between mice and human, and as we have recently shown that the function of miR-125a 
is indeed conserved between these two species12, we speculate that miR125a levels associate with stem cell expan-
sion and mobilization in humans as well.
It is likely that miR-125a induced expansion and mobilization, which we report in the current paper, is caused 
by (an interplay of) multiple target genes including c-Kit.
Materials and Methods
Mice. C57/BL/6 (B6) mice were purchased from Harlan, C57BL/6SJL were bred in the Central Animal Facility 
of the University Medical Center Groningen. All animal experiments were approved and performed according to 
guidelines of the University of Groningen Animal Care Committee.
Purification and transduction of BM cells. LSK48–150+, LSK depleted from CD48–150+ cell sorting 
and transduction were performed as previously described12. Briefly BM cells from bones of hind legs, spines and 
sterna of naïve, female B6 mice were crushed and stained with antibodies against Sca-1, c-Kit, CD48, CD150, 
CD3ε, Gr1, Ter119 and B220. Cells were sorted using MoFlo XDP and MoFlo Astrios (Beckman Coulter) cell 
sorters and prestimulated in StemSpan medium (STEMCELL Technologies) supplemented with 300 ng/ml stem 
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cell factor (SCF), 1 ng/ml Flt3 ligand (Amgen), and 20 ng/ml IL-11 (R&R Systems) for 24 h. Cells were transduced 
with viral supernatant containing barcoded MIEV or 633-miR125a vectors in RetroNectin-covered plates (Takara 
Bio Inc.) in the presence of 2 µg/ml polybrene (Sigma-Aldrich).
Barcoded libraries. MIEV library was constructed as previously described (Gerrits et al., 2010). To 
obtain 633-miR125a library the vector containing miR-125 was cut with PacI and SalI, synthesized oligos 
(IDT) were hybridized, ligated into the vector and used for bacteria (DH5α) transformation. Bacterial colo-
nies were grown in 2 ml culture, 4 colonies per tube, then mini-preps were performed, isolated DNA has been 
stored at-80. All preps were tested by PCR for the barcode region, as well as restriction analysis was done to 
discriminate barcoded and unbarcoded vectors. Note the current barcode version had a structure: (PacI)- 
GAATGGNNACNNAGNNCCATGGNNCANNCGNNTCTGGCG-(SalI). This included the NcoI restriction 
site within the barcode sequence (bold). In total we obtained 434 clones that were mixed in equal concentrations 
and used for transductions. Both vectors used for libraries construction are essentially the same MLV type of the 
retroviral vector with nearly identical LTR, psi regions and other sites essential for the integration of the virus and 
expression. The libraries are comparable in size, which allows direct comparative analysis.
Bone marrow cell transplantation. 20–24 h after the first transduction cells were transplanted into 
lethally irradiated recipients (9 Gy) in the presence of 1 million radioprotective cells from B6 mouse. Efficiency 
of gene transfer, measured by flow cytometry (LSR-II, BD) is given in Supplementary Table 1. Donors were 4 
months old and recipient animals were 2–4 months old. Donor and GFP chimerism were determined in blood 
every 4 weeks. For secondary transplantations 5 million whole BM cells were transplanted into lethally irradiated 
recipients. A fraction of mice presented in Fig. 3A (blue and green donor mice) were previously used22.
Q-PCR. MiR-125a overexpression level was measured as previously described18. For Socs3 and Stat3 expres-
sion we used previously published primers12,24.
G-CSF administration. To test the mobilization rate in control and miR-125a overexpressing cells, we per-
formed one injection of PEGylated G-CSF intraperitoneally (25 µg/mouse dissolved in PBS) 3 days prior the 
sacrifice. To confirm the efficiency of the mobilization we also injected 1 naive B6 mouse and scored CFUs in the 
blood sample.
Colony unit forming cell assay (CFU-GM). To test the clonogenic potential of control and miR-125a 
overexpressing cells non-treated with G-CSF we plated 100 000 cells isolated from the spleen or bone marrow or 
1 capillary (50 µL) of peripheral blood and scored colonies at day 7.
To analyze the sensitivity of control or miR-125a overexpressing cells we put 500 L-K+ GFP+ cells/plate, 
exposed cells to various concentrations of G-CSF (0–10 ng/ml) and scored colonies at day 7.
In order to assess the sensitivity of cells with and without miR-125 OE we injected mice with one dose of 
G-CSF. On day 3 we isolated L-K+ GFP+ cells and placed them in CFU-GM assay, on day 7 we scored colonies.
Isolation of L-K+ cells from different skeletal locations after transplantation. Transplanted 
recipients were sacrificed by cervical dislocation under isoflurane anesthesia. Bones were isolated separately into 
five groups: 1) bones of fore limbs and sternum (front); 2) left femur, tibia and left part of the pelvic bone (left hind 
bone); 3) right femur, tibia and right half of pelvic bone (right hind bones); 4) bones of spine, 5) bones of skull. 
After removal of muscles, cells were isolated by crushing in lysis solution (NH4Cl) and filtered through 100 -µm 
filter to remove debris. Nucleated cells were washed, counted and stained with an antibody cocktail. Cells were 
washed and resuspended in a 1 µg/ml solution of propidium iodide (PI). Antibodies were directed against c-Kit, a 
panel of lineage markers (Ter119, Gr1, B220, Mac1, CD3ε). Cells were sorted directly into tubes, spun down and 
used for further barcode analysis.
Clonal analysis of L-K+ cells. Genomic DNA was extracted from L-K+ cells as described previously14 
and barcoded DNA was amplified with primers against internal vector sequence30. For deep sequencing barcode 
region from each cell sample was amplified with specially tagged eGFP primers and un-tagged reverse primer 
(Rev YY1iPCR 5′CCAAACCTACAGGTGGGGTCTTTCATTC3′). DNA products were pooled together and 
sequenced as a single sample in Illumina 2500 HiSeq machine, rapid run, 100 bp long, according to the protocol 
of the manufacturer.
Clonal analysis of blood samples. Clonal analysis in blood was performed as previously described14. In 
brief blood samples were collected every 4 weeks for 4–6 months and at the moment of sacrifice. Erythrocytes 
were lysed in NH4Cl buffer, and cells were stained with fluorophore-conjugated antibodies against Gr1, B220, 
CD3ε, Ter11913, washed and resuspended in PI solution. Mature blood cells were purified by FACS. Viable (PI-) 
granulocytes (Gr1+ side scatter high), T cells (CD3ε), B cells (B220+) and erythroid cells (Ter119+) were sorted. 
Barcode sequence was determined as described above.
Barcode data processing. Data extraction was performed using in-house developed scripts in Python, Perl, 
R and VBA, as recently described14. Briefly high quality barcode reads were extracted using Motif Occurrence 
Detection Suite31. Barcodes were sorted by read frequencies from highest to lowest, and all minor barcodes fre-
quencies different by a single nucleotide (one base distance) were merged with the dominant major barcode. 
Unique barcodes with frequencies under 10 were removed (technical threshold). All samples with <1,000 reads 
were excluded from further analysis.
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Statistical analysis. For testing the statistical significance of variation of clone size among different bone 
groups, we calculated the relative standard deviation (RSD). For comparing RSD values between groups we used 
non-parametric Mann-Whitney test that allows comparison of not-normally distributed data. P-values were cal-
culated using Prism.
Correlation and linear regression analyses and p-values were derived using Prism (GraphPad Software), 
Python and R. Clones with potetnially multiple hits were identified on the basis of linear regression analysis, 
using a custom Python script and linregress () function from scipy stats library. The barcodes were considered as 
linked (multiple integration of the virus into the same cell-multiple hits) if the linear regression between any pair 
of BCs were in the range (1-slope) <0.1. For such thresholds, p-values were far below 10−10.
Barcodes were normalized, sorted from highest to lowest and used for the linear regression with Pearson 
correlation to count linked barcodes and therefore estimate the number of cells with single, double and higher 
vector copy number.
To visualize changes in the contribution and rank order of barcodes in serial transplantation experiments we 
included barcodes present >10 in the primary donor contributing >0.5% to Gr1+ cells and analyzed their con-
tribution in secondary recipients. For data visualization we used custom Python script and R river plot algorithm.
In this paper we have mainly used correlation coefficients (Pearson) as a measure of similarity between sam-
ples. This function is quantitative and have particular limitations, nevertheless is well known and broadly used, 
and when properly used provides sufficient statistical information.
All methods were carried out in accordance with regulations at the University Medical Centre of Groningen.
All experimental protocols were approved by the Animal Care Committee at the University of Groningen and 
National Bureau for Genetically Modified Organisms (Bureau GGO).
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